37
Views
1
CrossRef citations to date
0
Altmetric
Papers

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

, , , , , , , & show all
Pages 550-557 | Received 13 Feb 2008, Published online: 10 Jul 2009

References

  • Beck A, Steer R, Brown G. BDI-II Beck Depression Inventory manual. Harcourt Brace and Company, San Antonio, TX 1996
  • Benedict RH. Brief Visuospatial Memory Test—Revised. Psychological Assessments Resources, Odessa, TX 1997
  • Benedict RH, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test—Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychologist 1998; 12: 43–55
  • Benton A, Hamsher K, Sivan A. Multilingual aphasia examination. AJA Associates, Iowa City, IA 1994
  • Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004; 26: 307–319
  • CDC (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mort Wkly Rep 41: 1–19.
  • Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000; 12: 255–266
  • Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999; 52: 607–613
  • Diehr MC, Heaton RK, Miller W, Grant I. The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment 1998; 5: 375–387
  • Duff K, Westervelt HJ, McCaffrey RJ, Haase RF. Practice effects, test-retest stability, and dual baseline assessments with the California Verbal Learning Test in an HIV sample. Arch Clin Neuropsychol 2001; 16: 461–476
  • El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fatkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283–2296
  • Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000; 54: 927–936
  • Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997; 42: 679–688
  • Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002; 59: 923–928
  • Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment 1999; 6: 147–178
  • Golden C. Stroop Color and Word test. Stoelting, Chicao, IL 1978
  • Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Motor Skills 1977; 44: 367–373
  • Gronwall DM, Sampson H. The psychological effects of concussion. Auckland University Press, Auckland 1974
  • Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al. The HNRC 500—Neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995; 1: 231–251
  • Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan Battery: demographic corrections, research findings, and clinical applications. Psychological Assessment Resources, Odessa, TX 1991
  • Heaton RK, Taylor MJ, Manly JJ (2002). Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Clinical interpretation of the WAIS-III and WMS-III. Ledbetter M. San Diego: Academic Press.
  • Klove H. Clinical neuropsychology. Medical clinics of North America, F Forster. Saunders, New York 1963
  • Kongs S, Thompson L, Iverson G, Heaton RK. Wisconsin Card Sorting Test—64 card computerized version. Psychological Assessment Resources, Odessa, TX 2000
  • Letendre S, Capparelli EV, Ellis RJ, McCutchan JA. Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. Antimicrob Agents Chemother 2000; 44: 2173–2175
  • Letendre S, Ellis R, Grant I, McCutchan A, the HNRC Group (2001). The CSF concentration (conc)/IC50 ratio: a predictor of CNS antiretroviral (ARV) efficacy. In: Eighth Conference on Retroviruses and Opportunistic Infections. Chicago, Feb 5–8, 2001 Abstract K1004p.
  • Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol 2003; 60: 1406–1412
  • McNair D, Lorr M, Droppleman L. Profile of Mood States (POMS) manual. Educational and Industrial Testing Services, San Diego 1992
  • Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 1999; 55: 79–86
  • Price RW, Deeks SG. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: clinical and pathogenetic implications for the central nervous system. J NeuroVirol 2004; 10(Suppl 1)44–51
  • Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS 1999; 13: 1677–1685
  • Reddy YS, Kashuba A, Gerber J, Miller V. Roundtable report: importance of antiretroviral drug concentrations in sanctuary sites and viral reservoirs. AIDS Res Hum Retroviruses 2003; 19: 167–176
  • Reitan R, Wolson D. The Halstead-Reitan Neuropsychological Test Battery2nd ed. Neuropsychology Press, Tuscon, AZ 1993
  • Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, Carson VL, Sinclair B, Racenstein JM, Reed RA, Levine AM. Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy. J Int Neuropsychol Soc 2002; 8: 781–793
  • Ruiz L, Ribera E, Bonjoch A, Romeu J, Martinez-Picado J, Paredes R, Diaz M, Marfil S, Negredo E, Garcia-Prado J, Tural C, Sirera G, Clotet B. Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study. J Infect Dis 2003; 188: 977–985
  • Sattler JM. Assessment of children: cognitive applications4th ed. Jerome M. Sattler, La Mesa, CA 2001
  • Taylor S, Boffito M, Khoo S, Smit E, Back D. Stopping antiretroviral therapy. AIDS 2007; 21: 1673–1682
  • The Psychological Corporation. (1997). Wechsler Adult Intelligence Scale—Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
  • Touloumi G, Pantazis N, Antoniou A, Stirnadel HA, Walker SA, Porter K. Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences. J Acquir Immune Defic Syndr 2006; 42: 554–561
  • Tozzi V, Balestra P, Galgani SP, Narciso P, Ferri F, Sebastiani G, Amato CC, Affricano C, Pigorini F, Pau F, De Felici A, Benedetto A. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 1999; 13: 1889–1897
  • United States Army (1994). Army Individual Test Battery—manual of directions and scoring. Washington, DC: War Department, Adjutant General's Office.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.